Clinical Trial Update: Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy [Phase 3]

View source ↗

Summary

Phase 3 trial update for Tllsh2910 in ataxia (cerebellar) and multiple system atrophy, status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia Cerebellar
• Multiple System Atrophy

Drugs mentioned

• Tllsh2910

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Ataxia, Cerebellar, Multiple System Atrophy | Phase 3 | Status: TERMINATED